BioSpace News Archive

Mobile Hospitals Market is projected to cross US$ 52.8 Bn by 2031, Says TMR

According to the report, the global mobile hospitals market was valued at US$ 18 Bn in 2020 and is projected to expand at a CAGR of ~10% from 2021 to 2031.

April 26, 2022
·
6 min read
APEIRON shareholders approve new group structure geared towards enabling innovation and growth

APEIRON Biologics AG announces that the annual general meeting held yesterday has approved the new structure of the group through the demerger of its preclinical and clinical development activities and the creation of a new fully separate holding company, invIOs Holding AG.

April 26, 2022
·
4 min read
Biotech Beach

DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes

DexCom, Inc. will showcase for the first time its new global portfolio of real-time continuous glucose monitoring systems at the 15th International Conference on Advanced Technologies and Treatments for Diabetes held April 27-30, 2022 in Barcelona.

April 26, 2022
·
7 min read
Genetown

PureTech Announces Annual Results for Year Ended December 31, 2021

PureTech Health plc announced its results for the year ended December 31, 2021 as well as its cash balance as of the first quarter ended March 31, 2022.

April 26, 2022
·
117 min read
Genetown

CN Bio Introduces PhysioMimix NASH ‘in-a-box’ Reagent Kit

CN Bio, a leading Organ-on-a-chip Company that designs and manufactures single- and multi-organ microphysiological systems, introduced its PhysioMimix™ ‘in-a-box’ reagent kit for Non-alcoholic steatohepatitis, the most severe form of non-alcoholic fatty liver disease.

April 26, 2022
·
3 min read
Business

ROME Therapeutics Appoints Nurjana Bachman, Ph.D., as Senior Vice President, Corporate Development and Strategy

ROME Therapeutics, a biotechnology company harnessing the power of the repeatome for drug development, announced the appointment of Nurjana Bachman, Ph.D., as Senior Vice President, Corporate Development and Strategy.

April 26, 2022
·
3 min read
Business

Centene Corporation Reports First Quarter 2022 Results And Increases 2022 Guidance

Centene Corporation announced its financial results for the first quarter ended March 31, 2022, reporting diluted earnings per share of $1.44 and adjusted diluted EPS of $1.83.

April 26, 2022
·
30 min read
BioMidwest

SpineThera Awarded $5 Million Grant from Department of Defense

SpineThera, Inc. announced that the Department of Defense has awarded the company a grant for $4.97 million that will support development of SX600.

April 26, 2022
·
2 min read
Business

BioNTech to Report First Quarter 2022 Financial Results and Operational Update on May 9, 2022

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2022 on Monday, May 9th, 2022.

April 26, 2022
·
2 min read
Business

NeuroMetrix Reports Q1 2022 Financial Results

NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2022.

April 26, 2022
·
5 min read